Abstract
Non-small cell lung cancer (NSCLC) is prevalent worldwide and has a high mortality rate. Even if mesenchymal stem cells (MSCs) are suggested as cancer treatment, the studies of their effects on NSCLC cells contradict each other, mainly due to utilization of two-dimensional (2D) culture system. Three-dimensional (3D) culture systems resemble tissue organization in vivo. Here we comprehensively explore the inhibitory effects of MSCs on NSCLC cells in a 3D culture system. We confirmed that the inhibitory effects of 3D-cultured MSCs (3D-MSCs) on the proliferation and migration of NSCLC cells are greater than that of the 2D-cultured MSCs. The expression of IL-24 in 3D-MSCs is higher than 2D-MSCs, which is the key factor to enhance the anti-tumor effect of MSCs. In these cells, IL-24 affects p38 MAPK and CXCR4/AKT pathways. Overall, this study provides the support for use of MSCs in tumor therapy.
Similar content being viewed by others
REFERENCES
Siegel R.L., Miller K.D., Jemal A. 2019. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7‒34.
Wu Z., Qiu X., Gao B., Lian C., Peng Y., Liang A., Xu C., Gao W., Zhang L., Su P., Rong L., Huang D. 2018. Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells. J. Pineal. Res. 65, e12483.
Camorani S., Hill B.S., Fontanella R., Greco A., Gramanzini M., Auletta L., Gargiulo S., Albanese S., Lucarelli E., Cerchia L., Zannetti A. 2017. Inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRβ aptamer. Theranostics. 7, 3595‒3607.
Kupcova Skalnikova H. 2013. Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie. 95, 2196‒2211.
Li L., Tian H., Chen Z., Yue W., Li S., Li W. 2011. Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochim. Biophys. Sin. (Shanghai). 43, 143‒148.
Jung P.Y., Ryu H., Rhee K.J., Hwang S., Lee C.G., Gwon S.Y., Kim J., Kim J., Yoo B.S., Baik S.K., Bae K.S., Eom Y.W. 2019. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells. Cancer Lett. 440‒441, 202‒210.
Pan M., Hou L., Zhang J., Zhao D., Hua J., Wang Z., He J., Jiang H., Hu H., Zhang L. 2018. Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells. Mol. Cell. Biochem. 441, 63‒76.
Fakiruddin K.S., Lim M.N., Nordin N., Rosli R., Zakaria Z., Abdullah S. 2019. Targeting of CD133+ cancer stem cells by mesenchymal stem cell expressing TRAIL reveals a prospective role of apoptotic gene regulation in non-small cell lung cancer. Cancers (Basel). 11, 1261.
Kim S.W., Lee Y.K., Hong J.H., Park J.Y., Choi Y.A., Lee D.U., Choi J., Sym S.J., Kim S.H., Khang D. 2018. Mutual destruction of deep lung tumor tissues by nanodrug-conjugated stealth mesenchymal stem cells. Adv. Sci. (Weinh). 5, 1700860.
Gazdic M., Simovic Markovic B., Jovicic N., Misirkic-Marjanovic M., Djonov V., Jakovljevic V., Arsenijevic N., Lukic M.L., Volarevic V. 2017. Mesenchymal stem cells promote metastasis of lung cancer cells by downregulating systemic antitumor immune response. Stem Cells Int. 2017, 6294717.
Wang S., Li X., Xu M., Wang J., Zhao R.C. 2017. Reduced adipogenesis after lung tumor exosomes priming in human mesenchymal stem cells via TGFβ signaling pathway. Mol. Cell. Biochem. 435, 59‒66.
Luo D., Hu S., Tang C., Liu G. 2018. Mesenchymal stem cells promote cell invasion and migration and autophagy-induced epithelial-mesenchymal transition in A549 lung adenocarcinoma cells. Cell Biochem. Funct. 36, 88‒94.
Fregni G., Quinodoz M., Moller E., Vuille J., Galland S., Fusco C., Martin P., Letovanec I., Provero P., Rivolta C., Riggi N., Stamenkovic I. 2018. Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis. EBioMedicine. 29, 128‒145.
Caliari S.R., Burdick J.A. 2016. A practical guide to hydrogels for cell culture. Nat. Methods. 13, 405‒414.
DeVolder R., Kong H.J. 2012. Hydrogels for in vivo-like three-dimensional cellular studies. Wiley Interdisc. Rev. Syst. Biol. Med. 4, 351‒365.
Legant W.R., Chen C.S., Vogel V. 2012. Force-induced fibronectin assembly and matrix remodeling in a 3D microtissue model of tissue morphogenesis. Integr. Biol. (Camb.). 4, 1164‒1174.
Ravi M., Paramesh V., Kaviya S.R., Anuradha E., Solomon F.D. 2015. 3D cell culture systems: advantages and applications. J. Cell. Physiol. 230, 16‒26.
Zhao D., Hou L., Pan M., Hua J., Wang Z., He J., Hu H. 2018. Inhibitory effect and mechanism of mesenchymal stem cells cultured in 3D system on hepatoma cells HepG2. Appl. Biochem. Biotechnol. 184, 212‒227.
Chaudhuri O., Gu L., Klumpers D., Darnell M., Bencherif S.A., Weaver J.C., Huebsch N., Lee H.P., Lippens E., Duda G.N., Mooney D.J. 2016. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat. Mater. 15, 326‒334.
Pradhan A.K., Bhoopathi P., Talukdar S., Scheunemann D., Sarkar D., Cavenee W.K., Das S.K., Emdad L., Fisher P.B. 2019. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF. Proc. Natl. Acad. Sci. U. S. A. 116, 5687‒5692.
Bhutia S.K., Das S.K., Azab B., Menezes M.E., Dent P., Wang X.Y., Sarkar D., Fisher P.B. 2013. Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24. Int. J. Cancer. 133, 2726‒2736.
Sarkar D., Su Z.Z., Lebedeva I.V., Sauane M., Gopalkrishnan R.V., Valerie K., Dent P., Fisher P.B. 2002. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. U. S. A. 99, 10054‒10059.
Sauane M., Su Z.Z., Gupta P., Lebedeva I.V., Dent P., Sarkar D., Fisher P.B. 2008. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105, 9763‒9768.
Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87‒108.
Kang S., Bhang S.H., Hwang S., Yoon J.K., Song J., Jang H.K., Kim S., Kim B.S. 2015. Mesenchymal stem cells aggregate and deliver gold nanoparticles to tumors for photothermal therapy. ACS Nano. 9, 9678‒9690.
Shen W.C., Lai Y.C., Li L.H., Liao K., Lai H.C., Kao S.Y., Wang J., Chuong C.M., Hung S.C. 2019. Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis. Nat. Commun. 10, 2226.
Xu C., Lin L., Cao G., Chen Q., Shou P., Huang Y., Han Y., Wang Y., Shi Y. 2014. Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene. 33, 5047‒5052.
Ma Q., Jin B., Zhang Y., Shi Y., Zhang C., Luo D., Wang P., Duan C., Song H., Li X., Deng X., Chen Z., Wang Z., Jiang H., Liu Y. 2016. Secreted recombinant human IL-24 protein inhibits the proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro and in vivo. Oncol. Rep. 35, 2681‒2690.
Chen J., Gao P., Yuan S., Li R., Ni A., Chu L., Ding L., Sun Y., Liu X.Y., Duan Y. 2016. Oncolytic adenovirus complexes coated with lipids and calcium phosphate for cancer gene therapy. ACS Nano. 10, 11548‒11560.
Pradhan A.K., Talukdar S., Bhoopathi P., Shen X.N., Emdad L., Das S.K., Sarkar D., Fisher P.B. 2017. mda-7/IL-24 mediates cancer cell-specific death via regulation of miR-221 and the Beclin-1 axis. Cancer Res. 77, 949‒959.
Dash R., Azab B., Quinn B.A., Shen X., Wang X.Y., Das S.K., Rahmani M., Wei J., Hedvat M., Dent P., Dmitriev I.P., Curiel D.T., Grant S., Wu B., Stebbins J.L., et al. 2011. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc. Natl. Acad. Sci. U. S. A. 108, 8785‒8790.
Zhao Y., Li Z., Sheng W., Miao J., Yang J. 2013. Radiosensitivity by ING4-IL-24 bicistronic adenovirus-mediated gene cotransfer on human breast cancer cells. Cancer Gene Ther. 20, 38‒45.
Zhang J., Hou L., Zhao D., Pan M., Wang Z., Hu H., He J. 2017. Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells. Clin. Transl. Oncol. 19, 1358‒1374.
Takahara K., Ii M., Inamoto T., Nakagawa T., Ibuki N., Yoshikawa Y., Tsujino T., Uchimoto T., Saito K., Takai T., Tanda N., Minami K., Uehara H., Komura K., Hirano H., et al. 2016. microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer. Stem. Cells Dev. 25, 1290‒1298.
Panneerselvam J., Jin J., Shanker M., Lauderdale J., Bates J., Wang Q., Zhao Y.D., Archibald S.J., Hubin T.J., Ramesh R. 2015. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis. PLoS One. 10, e0122439.
Moro M., Bertolini G., Pastorino U., Roz L., Sozzi G. 2015. Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133+ tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer. J. Thorac. Oncol. 10, 1027‒1036.
Teng F., Tian W.Y., Wang Y.M., Zhang Y.F., Guo F., Zhao J., Gao C., Xue F.X. 2016. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis. J. Hematol. Oncol. 9, 8.
Tsou L.K., Huang Y.H., Song J.S., Ke Y.Y., Huang J.K., Shia K.S. 2018. Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology. Med. Res. Rev. 38, 1188‒1234.
Xu J., Liang J., Meng Y.M., Yan J., Yu X.J., Liu C.Q., Xu L., Zhuang S.M., Zheng L. 2017. Vascular CXCR4 expression promotes vessel sprouting and sensitivity to sorafenib treatment in hepatocellular carcinoma. Clin. Cancer Res. 23, 4482‒4492.
Dash R., Bhoopathi P., Das S.K., Sarkar S., Emdad L., Dasgupta S., Sarkar D., Fisher P.B. 2014. Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction. Cancer Res. 74, 563‒574.
Fan S., Gao H., Ji W., Zhu F., Sun L., Liu Y., Zhang S., Xu Y., Yan Y., Gao Y. 2020. Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas. J. Cell Physiol. 235, 1769‒1779.
Ma M., Zhao L., Sun G., Zhang C., Liu L., Du Y., Yang X., Shan B. 2016. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs. Oncol. Rep. 35, 3122‒3130.
Ma Y.F., Ren Y., Wu C.J., Zhao X.H., Xu H., Wu D.Z., Xu J., Zhang X.L., Ji Y. 2016. Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer. Mol. Immunol. 75, 11‒20.
Funding
This work was supported by the National Natural Science Foundation of China (81201762).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The authors declare that they have no conflict of interest. This article does not contain any research involving humans or animals as subjects of research.
ADDITIONAL INFORMATION
The text was submitted by the author(s) in English.
Rights and permissions
About this article
Cite this article
Suo, F., Pan, M., Li, Y. et al. Mesenchymal Stem Cells Cultured in 3D System Inhibit Non-Small Cell Lung Cancer Cells through p38 MAPK and CXCR4/AKT Pathways by IL-24 Regulating. Mol Biol 55, 589–603 (2021). https://doi.org/10.1134/S0026893321030110
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893321030110